Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Zender

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|November 24, 2025
Correction: An analysis of the distribution of bone and soft tissue sarcoma diagnoses and their disparities in Southwest Germany: a multicenter approachBranko Calukovic, Katrin Benzler, Mary E Carter, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Gastroenterology|September 11, 2016
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental ModelsIris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, et al.
Cancer Cell|October 6, 2009
Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma modelAnka Bric, Cornelius Miething, Carl Uli Bialucha, et al.
Journal of Hematology & Oncology|July 29, 2025
Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricideBeate Kristmann, Niels Werchau, Lakshmi Suresh, et al.
Journal of Medicinal Chemistry|March 14, 2022
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast CancerCarine M Abdelmalek, Zexi Hu, Thales Kronenberger, et al.
Journal of Medicinal Chemistry|March 24, 2025
Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer TherapiesJúlia Galvez B Pedreira, Pascal Woelffing, Moritz Schwarz, et al.
Nature|May 1, 2026
Author Correction: Titration of RAS alters senescent state and influences tumour initiationAdelyne S L Chan, Haoran Zhu, Masako Narita, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Cancer Research|June 19, 2021
MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal AdenocarcinomaBastian Krenz, Anneli Gebhardt-Wolf, Carsten P Ade, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|November 24, 2025
Correction: An analysis of the distribution of bone and soft tissue sarcoma diagnoses and their disparities in Southwest Germany: a multicenter approachBranko Calukovic, Katrin Benzler, Mary E Carter, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Gastroenterology|September 11, 2016
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental ModelsIris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, et al.
Cancer Cell|October 6, 2009
Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma modelAnka Bric, Cornelius Miething, Carl Uli Bialucha, et al.
Journal of Hematology & Oncology|July 29, 2025
Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricideBeate Kristmann, Niels Werchau, Lakshmi Suresh, et al.
Journal of Medicinal Chemistry|March 14, 2022
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast CancerCarine M Abdelmalek, Zexi Hu, Thales Kronenberger, et al.
Journal of Medicinal Chemistry|March 24, 2025
Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer TherapiesJúlia Galvez B Pedreira, Pascal Woelffing, Moritz Schwarz, et al.
Nature|May 1, 2026
Author Correction: Titration of RAS alters senescent state and influences tumour initiationAdelyne S L Chan, Haoran Zhu, Masako Narita, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Cancer Research|June 19, 2021
MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal AdenocarcinomaBastian Krenz, Anneli Gebhardt-Wolf, Carsten P Ade, et al.
Pageof 20